Australia's 4DMedical rises on establishing European platform via acquisition

4DMedical

01/06/2026 01:43

** Shares of 4DMedical 4DX.AX rise as much as 7.8% to A$4.28, their highest level since May 19
** The medtech firm establishes an immediate European commercial and clinical platform, expanding operations to a third major region alongside North America and ANZ
** Expansion accelerated via binding agreement to buy Austrian-based contextflow GmbH, a medical technology firm specialising in lung cancer screening, advanced AI-driven thoracic imaging, adds company
** Acquisition agreed on heavily discounted terms including upfront payments of A$18.56 million ($13.33 million) in cash, others
** Stock up 6.4% this year, including the day's move

($1 = 1.3926 Australian dollars)

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))